Aspirin, indomethacin and dazoxiben do not affect the fibrinolytic activation induced by venous occlusion
- 1 October 1985
- journal article
- research article
- Published by Elsevier in Thrombosis Research
- Vol. 40 (2) , 161-170
- https://doi.org/10.1016/0049-3848(85)90326-3
Abstract
No abstract availableKeywords
This publication has 31 references indexed in Scilit:
- Identification of plasminogen activator releasing activity in the neurohypophysisBritish Journal of Haematology, 1984
- Aspirin inhibits vascular plasminogen activator activity in vivo. Studies utilizing a new assay to quantify plasminogen activator activity.Journal of Clinical Investigation, 1984
- Influence of protein C activation on blood coagulation and fibrinolysis in squirrel monkeys.Journal of Clinical Investigation, 1984
- Prostacyclin and the fibrinolytic system in ischemic vascular diseaseThrombosis Research, 1983
- Effect of aspirin and sodium salicylate on thrombosis, fibrinolysis, prothrombin time, and platelet survival In rabbits with indwelling aortic cathetersBlood, 1983
- Generation of fibrinolytic activity by infusion of activated protein C into dogs.Journal of Clinical Investigation, 1981
- Prevention of venous thromboembolism after total knee replacement by high-dose aspirin or intermittent calf and thigh compression.BMJ, 1980
- On the Regulation and Control of FibrinolysisThrombosis and Haemostasis, 1980
- Increased Blood Fibrinolytic Activity after Aspirin IngestionNew England Journal of Medicine, 1977
- ASPIRIN AND BLOOD FIBRINOLYSISThe Lancet, 1970